A rating of 76 puts Lantern Pharma Inc (LTRN) near the top of the Biotechnology industry according to InvestorsObserver. Lantern Pharma Inc's score of 76 means it scores higher than 76% of stocks in the industry. Lantern Pharma Inc also received an overall rating of 54, putting it above 54% of all stocks. Biotechnology is ranked 73 out of the 148 industries.
LTRN has an Overall Score of 54. Find out what this means to you and get the rest of the rankings on LTRN!
Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 54 would rank higher than 54 percent of all stocks.
This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.
What's Happening With Lantern Pharma Inc Stock Today?
Lantern Pharma Inc (LTRN) stock is higher by 2.85% while the S&P 500 has fallen -1.02% as of 10:48 AM on Tuesday, Sep 26. LTRN is higher by $0.10 from the previous closing price of $3.51 on volume of 1,864 shares. Over the past year the S&P 500 has risen 17.46% while LTRN has fallen -21.35%. LTRN lost -$1.31 per share the over the last 12 months.
Click Here to get the full Stock Report for Lantern Pharma Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter